Table 1.
Association between miR-153 expression and clinical and pathological characteristics of patients with prostate cancer.
| Variables | Cases (n) | MiR-153 expression |
P-value | |
|---|---|---|---|---|
| High (n = 31) | Low (n = 30) | |||
| Age, years | ||||
| <55 | 15 | 9 | 6 | 0.818 |
| ≥55 | 46 | 24 | 22 | |
| Lymph node metastasis | ||||
| Yes | 29 | 22 | 7 | 0.180 |
| No | 32 | 18 | 14 | |
| Bone metastases | ||||
| Yes | 27 | 18 | 9 | 0.203 |
| No | 34 | 16 | 18 | |
| Gleason score | ||||
| <8 | 23 | 12 | 11 | 0.710 |
| ≥8 | 38 | 23 | 15 | |
| TNM stage | ||||
| I + II | 32 | 8 | 24 | 0.001 |
| IV | 29 | 23 | 6 | |
TNM, tumor, node, metastasis.